Novobiocin Sodium Salt, MP Biomedicals™

Description

Inhibits DNA synthesis by inhibiting the enzyme Topoisomerase II. Novobiocin Sodium Salt, MP Biomedicals is an antibiotic produced by Streptomyces nieveus. It is active against gram-positive bacteria. It is also a Hsp90 inhibitor 3.

Novobiocin inhibits DNA synthesis by inhibiting bacterial DNA gyrase targeting the GyrB subunit of the enzyme involved in energy transduction. It acts as a competitive inhibitor of the ATPase reaction catalysed by GyrB 2. Uses include:

• For the production of positively supercoiled plasmid DNA
• Inhibitor of bacterial DNA gyrase and eukaryotic DNA topoisomerase
• Inhibitor of retrovirus RNA-dependent DNA-polymerase
• To study heat shock protein inhibition

Specifications

Chemical Identifiers

• CAS: 1476-53-5
• Molecular Formula: C31H35N2NaO11
• Molecular Weight (g/mol): 634.61
• MDL Number: MFCD00066541,MFCD00066541
• InChI Key: AXOUUAINTJNFRS-UHFFFAOYNA-N
• Synonym: Albamycin, Cathomycin sodium
• PubChem CID: 131673945
• SMILES: [Na+].COC1C(OC(N)=O)C(O)C(OC2=CC=C3C(=O)[C-](NC(=O)C4=CC=C(O)C(CC=C(C)C)=C4)C(=O)OC3=C2C)OC1(C)C

• Physical Form: Powder
• Absorbance: λ max: 307nm
• Melting Point: 220°C
• Extinction Coefficient: E1%= 600 (0.1M NAOH)
• Potency: ∼900μg/mg
• Quantity: 25 g
• Optical Rotation: −38.0° (2.5g/100ml ethanol at 24°C for the free acid)
• Solubility Information: Freely soluble in water (10%, clear, colorless solution)
• IUPAC Name: [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate;molecular hydrogen;sodium
• Formula Weight: 634.6

Safety and Handling

Recommended Storage

Store at 2–8°C.

WARNING: Reproductive Harm - www.P65Warnings.ca.gov